To include your compound in the COVID-19 Resource Center, submit it here.
CLTR and partner SmithKline Beecham (LSE:SB;SBH, Philadelphia, Penn.) said that in a Phase II trial of Bexxar
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury